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Summary The oral cavity contains more than hundreds of microbial species. An increase in the
number of these microorganisms like high pathogenic potential species, such as cariogenic and
periodontopathic bacteria, and the change of microbial biota may result in, not only oral
infection, but also systemic diseases, such as infective endocarditis and aspiration pneumonia.
It is very important to control the growth of these microorganisms and its biota just after oral
cleaning in order to suppress disease onset. In this regard, it is useful to use the anti-microbial
component which acts against pathogenic microorganisms. Here, we highlight the importance of
catechin, and feature its possible oral, especially periodontal applications. By combining
catechin with gel (catechin gel), antimicrobial activity of catechin was prolonged in gel and
catechin anti-oxidization property was observed. Catechin gel inhibited the growth of the
Actinomyces, periodontopathic bacteria and Candida strains tested, but did not inhibit that
of the oral streptococci that are important in the normal oral flora. In contrast, commercially
available moisture gels containing antimicrobial components showed antimicrobial activity
against all of the tested strains including the oral streptococci. This show that catechin has
selective antimicrobial activity, attributable to hydrogen peroxide production. This paper
reviews previous works using catechin and, likewise, catechin gel may be show its possible oral
application for prevent dental caries and periodontal disease.
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Green Tea is a product made up from the leaf and bud of the
plant Camellia sinensis, and is classified into ‘non-fermen-
ted’ green tea (produced by drying and steaming the fresh
leaves to inactivate the polyphenol oxidase and thus, no
oxidation occurs) [1]. One of the major components of green
tea is catechin. Catechin are polyphenols that are grouped
into different kinds: (1) epigallocatechin (EGC); (2) epigallo-
catechin gallate (EGCG); (3) epicatechin (EC); (4) epicate-
chin gallate (ECG); (5) gallocatechin (GC); (6) catechin (C),
and (7) gallocatechin gallate (GCG).
Catechin are polyphenol chemical compounds that are
abundant in green tea and have been shown to exhibit
physiological effects, including antibacterial [2—5], antifun-
gal [6,7], antiviral [8—11], antioxidative [1,12], and antitu-
mor activities [13—15]. Recent studies have suggested that
catechins also promote oral health and contribute to a
reduced risk for some systemic disease [16,17]. However,
the advantageous effects of catechins are not evident in the
oral cavity, as it serves simply as a passage for catechins and
the use of catechin in oral care applications was uncommon.
2. Oral flora and plaque accumulation
Several microbial species reside in the human oral cavity
[18]. These are composed of indigenous microbial flora that
prevent the colonization and growth of foreign pathogens
which would have a beneficial effect to the host [19]. How-
ever, an increase in the number of indigenous flora could
cause infectious disease in the oral cavities (such as dental
caries or periodontal diseases) [20,21] and mature dental
plaques may be linked to systemic disease progression [22—
24]. Similarly, systemic diseases, such as infective endocar-
ditis [24,25], myocardial infarction [26], aspiration-related
pneumonia [27—29], premature birth and low weight birth
[30] may be linked to oral microbes.
During the dental plaque development, bacterial species
(such as Streptococcus spp.) adhere strongly to the tooth
forming an initial dental plaque [31]. These would be part of
the normal oral microbial flora which is mainly composed of
early colonizers forming a thin dental plaque which helps to
maintain the health of the host and prevent the adhesion and
proliferation of oral pathogenic microorganisms such as per-
iodontopathic bacteria [32]. It is essential to keep this thin
dental plaque for our oral health. As the existence ratio of
periodontal and other pathogens is very low and the growth
of these bacteria are late, the outer layer of these cells favor
adhesion to Streptococcus, Fusobacterium or Actinomyces
resulting in the accumulation and formation of mature patho-
genic dental plaque which subsequently results in the accu-
mulation of metabolic product [31,33,34]. The mature dental
plaque can develop to a biofilm and obstruct the penetrationof substances, such as chemotherapeutic agents and external
antibodies [35,36]. The combination of cell components
ingredient and metabolic product in dental plaque is con-
sidered detrimental to host tissues.
Currently, medical care for the old associated to sudden
increase of the senior citizen population has become a
primary concern. Among the leading cause of death among
senior citizens older than 60, pneumonia is the primary
cause. At the moment, pneumonia is the 4th leading cause
of death in Japan [37]. In the case of elderly person orally
eating where there is a decline in deglutition function,
aspiration-related pneumonia accounts for 70% of pneumonia
cases [38].
Previous reports associate aspiration to most oral micro-
organisms [28]. Dental plaque is the site for bacterial pro-
gression and one of the highest pathogenic factors in
aspiration-related pneumonia [29]. It has been reported that
this pneumonia can be prevented by professional mouth care
but mouth cleaning is difficult for the elderly, often requiring
a care worker’s assistance [39,40].
In addition, plaque and periodontopathic bacteria are not
only a source of focal infection but may also hold inflamma-
tory materials. Therefore, it is essential that the microbial
count present in the oral cavity be strictly controlled to
suppress serious diseases progression [41,42].
3. Medical application of catechin
Recently, catechin was suggested to contain antioxidative
activity and contribute to reducing cardiovascular risk and
some forms of cancer [43,44].
Antioxidant activity of catechin has previously been
assessed by several methods. Cao et al. [45] found that green
tea catechin has a much higher antioxidant activity against
peroxyl radicals. Similarly, Saffari and Sadrzadeh [12] inves-
tigated the EGCG antioxidant capacity using membrane-bound
erythrocyte. This would suggest that catechin may contribute
to anti-oxidative stress damage. Similarly, catechin has anti-
hypertensive effect and can prevent cardiovascular disease
[46]. Some studies suggest that catechin can protect against
neurodegenerative diseases like Parkinson’s and Alzheimer’s
diseases and which would indicate epigenetic activity [47,48].
Furthermore, numerous studies have also demonstrated that
the aqueous extracts of GTP possesses anti-inflammatory and
hypocholesterolemic properties [49].
The effects of EGCG on antioxidant, dietary, obese,
human malaria, cardiac muscle function, prostate cancer,
innate immune receptor and cardiac muscle function has all
been reported [50—56]. EGCG, exerts a growth inhibitory
effect in cancer cells suggesting it possesses a promising
anticancer potential due to its antioxidant, antimutagenic
and chemopreventive properties [57]. Yu et al. [58] reported
that EGCG inhibited the growth of prostate cancer adenoma
128 M. Tamura, K. Ochiaicells and induced apoptosis. EGCG is also considered to be a
topic protector agent against some types of radiation since it
prevents skin disease, photoaging and potential cancer pro-
blems due to prolonged exposure [59]. Some investigations
have also shown that EGCG does not only regulate the glucose
level in blood, but also may rehabilitate damaged beta-cells,
which are responsible for producing insulin [1].
The effect of EG on prostate cancer [55], and the effect of
EC on prostate cancer, prevent stroke damage, fatigue resis-
tance and oxidative capacity [56,60,61] has been previously
described. Likewise, the effect of C and GC on blood circula-
tion, fracture, chromic gastritis, rheumatoid arthritis and
irregular menstruation has been shown [62].
Despite this information, few reports have described the
catechin clinical application in the oral cavity.
4. Catechin gel as a plaque control reagent
The prevention of dental plaque formation, accumulation
and maturation as a result of poor oral care is important for
the control of both oral and systemic diseases. Thus, the
development of novel and more effective oral hygiene meth-
ods are essential. At the moment, plaque control mainly
involves mechanical means (such as toothbrushing, dental
floss, and interdental brushing), however, this alone is often
insufficient. Therefore, a number of chemical agents are
often used to support mechanical-based plaque control,
including topical antibiotics [63], chlorhexidine [64], povi-
done-iodine [65], xylitol [66], fluoride [67], and others [68].
However, side-effects associated with these agents have
been reported, including unpleasant taste, tooth discolora-
tion, irritation, and the induction of painful lesions in the oral
mucosa [67,69]. Some reports have confirmed the emergence
of drug-resistant strains of bacteria against xylitol or anti-
biotics [70,71] which would imply the need for a chemical
plaque control reagent with a strong anti-plaque effect and
causing no side-effects.
Among the several beneficial properties of catechin,
catechins antimicrobial activity would have beneficial
effects against oral diseases. However, few reports have
described the clinical applications of catechins in the oral
cavity since EGCG is readily absorbed by the digestive tract
and distributed to many animal and human organs. Generally,
catechin solutions are held for only a very short time in the
oral cavity which is not sufficiently enough time for anTable 1 Antimicrobial activity of catechin gel.
(a) Gram positives 
S. mutans ATCC25175 0.75 
S. mtis ATCC903 >3.00
S. sanguinis ATCC10556 >3.00
S. oralis ATCC10557 >3.00 
S. gordonii ATCC10558 >3.00 
A. naeslundii ATCC12104 0.09 
L. casei IFO3353 >3.00 
L. salivarius TI2711 >3.00 
S. aureus 209P 0.38 
MRSA NUD-101 0.38 
Minimal inhibitory concentration of agar diffusion assay (MIC-ADM: mgeffective antimicrobial action [72]. Moreover, catechin anti-
microbial activity against the many species of oral micro-
organisms is not fully elucidated. Understanding the range of
catechin antimicrobial activity and developing methods to
prolong catechin duration in the oral cavity would be essen-
tial to achieve oral health benefits.
Catechin gel (gel-entrapped catechins) is a mixture of
catechin and a gel that can be applied to the oral cavity of
elderly patients [41]. The gel would enable catechins to be
retained in the oral cavity prolonging catechin action. Moist-
ure gel without catechin showed no effect against all
employed strains in this study.
Minimal inhibitory concentration (MIC) by microdilution
assay and agar diffusion methods (ADM) was used to show
absence turbidity and the occurrence of growth inhibitory
zones using catechin gel and catechin components [41]. From
the 28 microbial strains used, the MIC-ADM difference was
found in each strain used (Table 1). Antimicrobial activity of
catechin gel was observed in all strains of Streptococcus
mutans, Actinomyces naeslundii, Staphylococcus aureus
including MRSA, Candida albicans, Fusobacterium nuclea-
tum, and periodontopathic bacteria. MIC-ADM values were
less than 0.10 mg/ml against Prevotella intermedia, F. nucle-
atum, A. naeslundii, and Porphyromonas gingivalis. In con-
trast, no growth inhibition zone was observed for early
colonizing streptococci, including Streptococcus mitis, S.
sanguinis, S. oralis, and S. gordonii, or for Lactobacillus or
Escherichia. These bacterial strains appeared to be resistant
to the antibacterial activity of catechins. The highest con-
centration (2.50 mg/ml) was found in Prevotella nigrescens,
one of the periodontal pathogens. These results established
the ideal concentration (2.75 mg/ml) for use in future studies
in clinical applications. It is worth mentioning, that the
catechin concentration in a tea beverage is 2—3 mg/ml
[73], which would imply that the catechin concentration
(2.75 mg/ml) is enough for clinical use.
Diameters of the growth inhibition zones produced by
catechin gel and EGCG gel (as a positive control) using the
gel diffusion method are shown (Fig. 1) [41]. Catechin gel
displayed antibacterial effects against oral pathogenic
microorganisms, with inhibition zones evident for all tested
strains of A. naeslundii, S. mutans, C. albicans, S. aureus and
periodontopathic bacteria. Notably, the diameters of the
growth inhibition zones for Actinomyces and S. aureus were
greater than 20 mm. The antibacterial effects of catechin gel
were similar to, or in some cases greater than, to those of(b) Fungi
C. albicans NUD-201 0.38
(c) Gram negatives
P. gingivalis ATCC33277 0.09
P. intermedia ATCC25611 0.05
P. nigrescens ATCC33563 2.50
A. a. Y4 0.75
F. nucleatum JCM6328 0.05
E. coli 12D-5203 >3.00
/ml).
A. naeslund ii
ATCC12104
WVU627
S. aureus
209P
Cowa n I
S. mutans
ATCC25175
MT8148
S. go rdoni i
ATCC10558
S. mitis
ATCC90 3
L. casei
IFO335 3
S. sanguini s
ATCC10556
MRSA
NUD-10 2
Diameter of  inhibition zone (mm)
Diameter of  inhibition
 zone (mm)
Diameter of  inhibition
 zone (mm)
10*            15            20              25             30            35
F. nu clea tum
JCM63 28
JCM110 23
A.a.
Y4
P. gingiva lis
ATCC332 77
FDC3 81
P. in termedia
ATCC25 611
E. coli
12D-520 3
K12-C100
Gram po sitives Fungu s
* Well  Φ: 10 mm
EGCg gel
Catech in ge l
Gram negatives
C. albica ns
NUD-20 1
NUD -20 2
10*            15             20  
10*            15             20  
S. oralis
ATCC10557
L. saliva rius
TI2711
P. nigres cens
ATCC33563
Figure 1 Optimum antimicrobial activity of catechin gel. Bars indicate the diameters of the growth inhibition zones produced by
catechin gel (white bars) and EGCG gel (black bars) for the listed strains. The diameter of the well was 10 mm. (a) Gram-positive
bacteria and fungi. (b) Gram-negative bacteria. Catechin concentration used was 2.75 mg/ml.
Antimicrobial activity of catechin gel 129EGCG gel. In contrast, no growth inhibition zone was
observed for early colonizing streptococci (S. mitis, S.
sanguinis, S. oralis, and S. gordonii), Lactobacillus or
Escherichia. These bacterial strains appeared to be resis-
tant to the antibacterial activity of catechins, this would
imply that catechins may be useful for the control of
dental plaque accumulation, since it was formed efficient
against Actinimyces and Fusobacterium (plaque-causing
bacteria) [31,33,34]. Antimicrobial effects of catechins
were also observed against Staphylococcus strains (includ-
ing MRSA, which cause suppuration-related inflammation
and bedsores [74]) and Candida (which causes oral candi-
diasis [75]) suggesting that catechins may aid in the pre-
vention of oral candidiasis and suppuration as well.
Moreover, it has been suggested that the ability of cate-
chins to inhibit the growth of Staphylococcus, C. albicans,
and periodontopathic bacteria may help to suppress aspira-
tion pneumonia [29,76].
Unlike the commercial gels, catechin gel did not show
antimicrobial activity against early colonizing oral strepto-
cocci such as S. sanguinis, S. oralis, S. gordonii and S. mitis
streptococci which are part of the normal oral microbial flora
and help maintain healthy oral cavity by preventing the
adhesion and proliferation of some pathogenic microorgan-
ism [32]. Early colonizing streptococci have been associated
with low numbers of periodontopathic bacteria and the
absence of periodontal disease [77]. It is very important to
keep the thin layer of bacterial accumulation formed during
the early stage of dental plaque since it possess low patho-
genicity. Therefore, it is necessary to not only suppress the
oral pathogenic microorganisms that cause disease but also
to protect the oral flora that play an important role in innate
immunity and catechin gel can efficiently do so.5. Advantages of catechin gel over catechin
A comparison between catechin gel and catechin solution
mixed solution is show in Fig. 2 [78]. The quantity of residual
catechin was measured by spectrophotometer [73]. Most of
the catechins in solution were removed after first washing,
whereas more than 90% of the catechins in catechin gel
remained after five rounds of washing (Fig. 2a). The differ-
ence in residual catechins between the catechin gel and the
solution was significant ( p < 0.01). The inhibition zones for S.
mutans were similar between washed and non-washed cate-
chin gel (Fig. 2b). In contrast, the catechin solution produced
no growth inhibition after the first wash. Same results were
observed against A. naeslundii and S. aureus. Furthermore,
incubation of S. mutans either with catechin gel or solution
showed that the antimicrobial activity of the catechin gel
was higher than that of catechin solution and was nearly
equivalent to that of freshly prepared one (Fig. 2c). This
further supports the possible clinical applications of catechin
gel. Same results were also observed against A. naeslundii
and S. aureus. It is worth mentioning that when comparing
catechin gel with other commercially available moisture gels
containing antimicrobial agents such as gel A (containing
lactoperoxidase, glucose oxidase, lysozyme, and lactoferrin)
and gel B (containing cetylpyridinium chloride), the results
showed that the antimicrobial activity of catechin gel was
higher than that of commercially available gels, each of
which contained antimicrobial agents directed against the
pathogenic microorganisms examined (Fig. 3) [41]. Surpris-
ingly, both commercial gels inhibited the growth of oral
streptococci suggesting that these gels appear to lack selec-
tive antimicrobial action. The catechin gel showed both
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Figure 2 Height catechin retention was detected in catechin gel. (a) The percentage of catechins remaining after a series of washes
with artificial saliva. There was a significant difference between catechin gel (^) and catechin solution (&) ( p < 0.01). (b)
Antimicrobial activities of catechin gel and solution after a series of washes with artificial saliva. Values are the diameters of the
growth inhibition zones of S. mutans ATCC25175 produced by catechin gel (^) and catechin solution (&) after each wash cycle. There
was a significant difference between the catechin gel and solution ( p < 0.01). (c) Antimicrobial activities of the catechin gel and
solution after incubation at 37 8C for 24 h. Values are the diameters of the growth inhibition zones of S. mutans ATCC25175 produced by
catechin gel (*), catechin solution (&) and freshly prepared catechin gel (^). After a 24-h incubation, the catechin gel and solution
showed significantly different antimicrobial activity ( p < 0.01).
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Figure 3 Comparison between catechin gel and commercial
gels. Diameters of the microbial growth inhibition zones pro-
duced by catechin gel and the commercially available gels A and
B. White bars, catechin gel. Gray bars, gel A. Black bars, gel B.
The well diameter was 10 mm.
Figure 5 Schematic illustration of relationship between hy-
drogen peroxide and NADH:hypothiocyanate oxidoreductase
(NHOR) in oral cavity [80].
Antimicrobial activity of catechin gel 131higher antimicrobial activity than commercially available
gels and selective antimicrobial activity.
6. Mechanisms of antimicrobial activity
Catechin antimicrobial activities are mainly dependent on
the charges and tertiary structure of the target molecule.
EGCG caused strong aggregation and NPN-fluorescence
quenching of PC-liposomes and these actions were markedly
lowered in the presence of negatively charged lipids [79].
These results show that bactericidal catechins primarily act
on and damage bacterial membranes [80]. In addition, some
reports have indicated that catechins promote the produc-
tion of hydrogen peroxide [81,82]. Authors reported that
catalase prevented catechin gel-induced growth inhibition
of S. mutans, A. naeslundii [38] and, likewise, the antimi-
crobial activity was dependent mainly on hydrogen peroxide
and significant quantities of hydrogen peroxide were pro-
duced by S. mitis, S. sanguinis, S. oralis, and S. gordonii
(Fig. 4) [41]. By comparison, less hydrogen peroxide was0
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Figure 4 Hydrogen peroxide production. The bars indicate the
concentrations of hydrogen peroxide produced by the listed
microbial strains.produced by S. mutans and A. naeslundii. Previous studies
have reported that Streptococcus spp. and most A. naeslundii
strains lack catalase activity [83] and that the alpha-hemo-
lytic activity of S. gordonii is related to the production of
hydrogen peroxide [84].
7. Proposed antimicrobial activity in the oral
cavity
Some commensal bacterium is protected against the dele-
terious effect of hypothiocyanite (OSCN) which is produced
by oral peroxidases (salivary peroxidase, myeloperoxidase)
or lactoperoxidase in the presence of thiocyanate (SCN) and
hydrogen peroxide [85]. This resistance was previously
attributed to the activity of a bacterial NADH:hypothiocya-
nate oxidoreductase (NHOR) which can reduce hypothiocya-
nite into thiocyanate with no effect on the bacterium (Fig. 5)
[86]. Thus, we previously examined the detoxification ability
of OSCN with hydrogen peroxide generated from catechin
[87]. As NHOR activity could not be measured directly,
activity was measured based on NADH2 consumption which
was indispensable to enzymatic reaction [88]. S. mitis, S.
sanguinis, S. oralis and S. gordonii used NHOR for enzymatic
activity. On the other hand, most of the NADH2 consumption
was not recognized as is the case of S. mutans and A.
naeslundii (Fig. 6) [86]. From this result, it seems that
catechin in an environment with oral peroxidase has an
antibacterial effect against S. mutans and A. naeslundii,
but not towards streptococci.0
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Figure 6 Consumption of NADH2 [81]. The consumption of
NADH2 was accompanied by NHOR activity.
132 M. Tamura, K. Ochiai8. Conclusion
This review presents a detailed overview of the advantage
and benefits of catechin. In addition, we highlight the pos-
sible use of catechin gel against oral diseases, such as dental
caries, periodontal diseases and candidiasis.
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